Sleep medication to help smokers quit or cut back
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a new sleep medication, daridorexant, can help smokers sleep better and feel more alert during the day, while also supporting their efforts to quit or reduce smoking. You will monitor your sleep at home, keep a diary, and take short mobile tests for 3 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old and smoke more than 10 cigarettes a day.
- You have been smoking for at least 1 year.
- You are willing to try to cut back or stop smoking for 3 weeks during the study.
- You are willing to wear a sleep monitor at home and keep a simple sleep and smoking diary for 3 weeks.
- You have an iPhone (preferably with iOS 17 or newer) and can travel to 3 study visits.
- You are not currently taking any smoking cessation medications, sleep aids, or certain other drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.
This study tests whether improving sleep can help people quit smoking and avoid relapse. It uses brain scans, a quitting medication, and counseling.
This study tests whether a new sleep medication called daridorexant helps people with depression who also struggle with insomnia. You would take this medication for several weeks while researchers track how it affects your sleep and mood.
This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
This Phase 2 study tests whether kava can help people quit smoking, especially by reducing stress and improving sleep during tobacco abstinence. You may be offered kava as part of a quitting support plan and monitored for safety and progress.
Hear when a new Nicotine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.